XHS Performance — State Street(R) SPDR(R) S&P(R) Health Care Services ETF
Data updated: 2026-09-11
XHS returned +23.55% year to date and +32.90% over one year to Jun 2026. Annualised returns are +12.41% over 3 years and +3.16% over 5 years. Against its Health Care Equity category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $142, against $138 for the category, and to $133 over one year, against $137. Volatility over the past three years was 21.37% a year. In the 12 months to Jun 2026 the fund took in a net $25.8M, and assets reached $139.88M.
XHS Growth of $100
What $100 invested in State Street(R) SPDR(R) S&P(R) Health Care Services ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | XHS | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $133 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $142 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $117 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $206 | $182 |
XHS Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +23.55% |
| 1 year | +32.90% |
| 3 years (annualised) | +12.41% |
| 5 years (annualised) | +3.16% |
XHS Annual Returns
Calendar-year total returns of State Street(R) SPDR(R) S&P(R) Health Care Services ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +23.55% |
| 2025 | +18.73% |
| 2024 | +1.86% |
| 2023 | +5.10% |
| 2022 | −19.85% |
| 2021 | +9.82% |
| 2020 | +33.32% |
| 2019 (Jul–Dec) | +11.78% |
XHS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.1% | +1.4% | −7.4% | +9.6% | +4.2% | +15.2% | — | — | — | — | — | — |
| 2025 | +13.0% | −4.3% | +0.4% | −2.3% | +1.6% | +2.4% | −9.7% | +10.6% | +2.3% | +1.0% | +7.9% | −3.4% |
| 2024 | −2.4% | +4.0% | +5.1% | −6.8% | +4.1% | −2.1% | +9.8% | +0.1% | −1.9% | −4.7% | +6.0% | −7.7% |
| 2023 | +9.2% | −1.7% | −5.0% | +3.6% | −3.6% | +8.6% | +0.2% | −5.2% | −6.4% | −4.7% | +6.8% | +5.0% |
| 2022 | −13.4% | +3.4% | +6.7% | −13.7% | −0.9% | −4.9% | +15.4% | −2.4% | −5.4% | +4.7% | −2.4% | −5.3% |
| 2021 | +6.5% | −1.3% | +4.5% | +3.5% | +2.4% | +1.6% | −2.1% | −0.6% | −6.3% | +1.8% | −7.3% | +8.0% |
| 2020 | −1.1% | −6.2% | −14.5% | +10.9% | +9.2% | −2.6% | +11.6% | +2.5% | −0.6% | +1.4% | +14.3% | +8.0% |
| 2019 | — | — | — | — | — | — | +2.5% | −6.2% | −2.5% | +3.8% | +11.8% | +2.8% |
XHS Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 21.37%
- 3-year Sharpe ratio: 0.37 (vs 4.5% risk-free rate)
- Best month: +15.19% (Jun 2026)
- Worst month: −9.68% (Jul 2025)
XHS Fund Flows
Monthly money in and out of State Street(R) SPDR(R) S&P(R) Health Care Services ETF, from SEC Form N-PORT.
- 12-month net flow: $25.8M
- 12-month gross sales (incl. reinvestments): $69.6M
- Sales ÷ redemptions: 1.59×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $21.2M | $0 | $21.2M |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $8.5M | $1.1M | $7.5M |
| Mar 2026 | $14.2M | $17.4M | −$3.2M |
| Feb 2026 | $0 | $5.4M | −$5.4M |
| Jan 2026 | $16.1M | $3.3M | $12.9M |
| Dec 2025 | $3.2M | $4.3M | −$1.1M |
| Nov 2025 | $1.0M | $0 | $1.0M |
| Oct 2025 | $5.2M | $1.0M | $4.2M |
| Sep 2025 | $0 | $3.0M | −$3.0M |
| Aug 2025 | $0 | $4.7M | −$4.7M |
| Jul 2025 | $0 | $3.6M | −$3.6M |
XHS Assets Under Management
Net assets of State Street(R) SPDR(R) S&P(R) Health Care Services ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $139.88M |
| 2026-03-31 | $82.26M |
| 2025-12-31 | $83.38M |
| 2025-09-30 | $75.23M |
| 2025-06-30 | $85.61M |
| 2025-03-31 | $88.17M |
| 2024-12-31 | $70.42M |
| 2024-09-30 | $82.40M |
| 2024-06-30 | $81.89M |
| 2024-03-31 | $89.15M |
| 2023-12-31 | $96.96M |
| 2023-09-30 | $97.41M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.